PeriBeam®, the FDA listed Pericardial Membrane, manufactured by TamaBio, a FDA registered establishment, was exported to the United States for the first time this week.
PeriBeam® is beginning to be widely used in cardiac surgery in Japan, primarily in pediatrics, and has been used clinically in over several hundred cases with no reported malfunctions.
TamaBio Company Limited
Head Office : 402 Gran Creste 2-2-18 Sakai Musashino-shi Tokyo 180-0022 Japan
Medical device manufacturing / Class 1 manufacturing and sales Development
Manufacturing, and Distributuon of Class IV highly controlled medical devices
(dura mater and pericardial prosthesis material)
Development, manufacturing, and sales of regenerative medical devices and other synthetic artificial biomembranes
Managing Director / CEO : Tetsuya Nagao
TEL : +81-422-53-5051 / FAX : +81-422-38-5091